Deep Brain Stimulation Systems Market, By Product Type (Single-channel Deep Brain Stimulator and Dual-channel Deep Brain Stimulator), By Application (Parkinson's Disease, Essential Tremor, Obsessive Compulsive Disorder, Epilepsy, Dystonia, and Other Applications), By End User (Hospitals, Ambulatory Surgical Centers, Neurological Clinics, and Other End Users), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

Deep Brain Stimulation Systems Market is expected to reach US$ 5.5 billion by 2034, growing at a 14.6% CAGR from its 2024 valuation of US$ 1.6 billion.

Deep brain stimulation is a surgical technique that includes implanting a gadget that sends electrical signals to the parts of the brain in charge of motor coordination. A lead, an extension, and a neurostimulator are all implanted inside the patient's body to form a deep brain stimulation (DBS) system. The pacemaker device synchronizes electrical pulses through the lead's connection to the brain. DBS devices assist in reducing the rigidity and tremor brought on by several neurological conditions, including essential tremor, dystonia, and Parkinson's disease. Patients may reduce their drug dosage following deep brain stimulation surgery, removing any potential adverse effects.

The growing prevalence of neurological disorders is one of the main drivers of the deep brain stimulation systems market's expansion. The need for a target market has arisen since Parkinson's disease is becoming more commonplace on all continents. The rising incidence of essential tremors will drive the demand for DBS devices, and dystonia will be a crucial factor driving the growth of the deep brain stimulation systems market.